Article
A novel STAT1 mutation associated with disseminated mycobacterial disease.
Journal of clinical immunology - 1 Aug 2012
Sampaio Elizabeth P, Bax Hannelore I, Hsu Amy P, Kristosturyan Ervand, Pechacek Joseph, Chandrasekaran Prabha, Paulson Michelle L, Dias Dalton L, Spalding Christine, Uzel Gulbu, Ding Li, McFarland Elizabeth, Holland Steven M
Abstract excerpt
STAT1 is a key component of Interferon (IFN)-γ and IFN-α signaling and mediates protection against mycobacteria, fungal, viral infections, and cancer. Dominant negative inhibitory as well as gain of function heterozygous STAT1 mutations demonstrate that IFN-γ driven cellular responses need to be tightly regulated to control infections. We describe an autosomal dominant mutation in the SH2 domain of STAT1 that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
